Hospital 12 de Octubre
Hospital 12 de Octubre
Madrid, Spain13 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies | Fanconi anemia complementation group D1, Fanconi anemia complementation group N, microphthalmia, syndromic 9 | Recruiting | Phase 1 | 2026-09-02 | NCT06458712 | |
| A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal cancer, esophageal disorder, gastric cancer, gastric neoplasm, head and neck squamous cell carcinoma, intestinal disorder, neoplasm, non-small cell lung carcinoma, rectal disorder, squamous cell carcinoma, stomach disorder | Recruiting | Phase 1 / Phase 2 | 2026-07-29 | NCT03526835 | |
| Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients | splenic marginal zone lymphoma | Active, not recruiting | Phase 3 | 2026-07-22 | NCT05735834 | |
| BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, cholangiocarcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, gastric cancer, gastric neoplasm, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder, stomach disorder | Recruiting | Phase 1 / Phase 2 | 2026-05-18 | NCT04421820 | |
| Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-05-14 | NCT05296746 | |
| A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours | Solid Tumours | Recruiting | Phase 1 / Phase 2 | 2026-05-08 | NCT06725758 | |
| Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment | cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiency | Enrolling by invitation | Not stated | 2026-05-08 | NCT05825898 | |
| The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR | cardiovascular disorder, heart disorder, heart failure, heart valve disorder, mitral valve insufficiency | Recruiting | Not applicable | 2026-04-13 | NCT03142152 | |
| SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-02-27 | NCT03589222 | |
| The Safety and Feasibility of the eLym™ System | Heart; Decompensation, Congestive | Recruiting | Not applicable | 2026-01-07 | NCT05747196 | |
| MYTHS - MYocarditis THerapy With Steroids | cardiomyopathy, cardiovascular disorder, heart disorder, myocarditis | Recruiting | Phase 3 | 2025-07-31 | NCT05150704 | |
| A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, endocrine system disorder, lethal congenital contracture syndrome 2, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic neoplasm, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2025-04-29 | NCT02912949 | |
| Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years | Newly Diagnosed Multiple Myeloma | Active, not recruiting | Phase 3 | 2022-09-14 | NCT03742297 |